Full Name
Elyse Blazevich
Speaker Bio
Colorado BioScience Association President and CEO Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. With the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation. Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents.
Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors. She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the team at Securisyn Medical, she: • Secured $15 million in capital, including $4 million in non-dilutive government funding. • Developed and expanded a product pipeline from one to five devices. • Built an intellectual property portfolio with 12 patents. • Completed two Phase I and subsequent Phase II SBIR contracts. • Achieved 510(k) market clearance for a Class II medical device. • Championed state programs run by the Office of Economic Development and International Trade to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical. Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA. Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors. She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the team at Securisyn Medical, she: • Secured $15 million in capital, including $4 million in non-dilutive government funding. • Developed and expanded a product pipeline from one to five devices. • Built an intellectual property portfolio with 12 patents. • Completed two Phase I and subsequent Phase II SBIR contracts. • Achieved 510(k) market clearance for a Class II medical device. • Championed state programs run by the Office of Economic Development and International Trade to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical. Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA. Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
Speaking At
